RATIONALE: The impact of COVID-19 on patients with Interstitial Lung Disease (ILD) has not been established. OBJECTIVES: To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age, sex and comorbidity matched population. METHODS: An international multicenter audit of patients with a prior diagnosis of ILD admitted to hospital with COVID-19 between 1 March and 1 May 2020 was undertaken and compared with patients, without ILD obtained from the ISARIC 4C cohort, admitted with COVID-19 over the same period. The primary outcome was survival. Secondary analysis distinguished IPF from non-IPF ILD and used lung function to determine the greatest risks of death. MEASUREMENTS AND MAIN RESULTS: Data from 349 patients with ILD across Europe were included, of whom 161 were admitted to hospital with laboratory or clinical evidence of COVID-19 and eligible for propensity-score matching. Overall mortality was 49% (79/161) in patients with ILD with COVID-19. After matching ILD patients with COVID-19 had higher mortality (HR 1.60, Confidence Intervals 1.17-2.18 p=0.003) compared with age, sex and co-morbidity matched controls without ILD. Patients with a Forced Vital Capacity (FVC) of <80% had an increased risk of death versus patients with FVC ≥80% (HR 1.72, 1.05-2.83). Furthermore, obese patients with ILD had an elevated risk of death (HR 2.27, 1.39-3.71). CONCLUSIONS: Patients with ILD are at increased risk of death from COVID-19, particularly those with poor lung function and obesity. Stringent precautions should be taken to avoid COVID-19 in patients with ILD. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).
- Drake, T. M.
- Docherty, A. B.
- Harrison, E. M.
- Quint, J. K.
- Adamali, H.
- Agnew, S.
- Babu, S.
- Barber, C. M.
- Barratt, S.
- Bendstrup, E.
- Bianchi, S.
- Castillo Villegas, D.
- Chaudhuri, N.
- Chua, F.
- Coker, R.
- Chang, W.
- Crawshaw, A.
- Crowley, L. E.
- Dosanjh, D.
- Fiddler, C. A.
- Forrest, I. A.
- George, P. M.
- Gibbons, M. A.
- Groom, K.
- Haney, S.
- Hart, S. P.
- Heiden, E.
- Henry, M.
- Ho, L. P.
- Hoyles, R. K.
- Hutchinson, J.
- Hurley, K.
- Jones, M. G.
- Jones, S.
- Kokosi, M.
- Kreuter, M.
- Mackay, L. S.
- Mahendran, S.
- Margaritopoulos, G.
- Molina-Molina, M.
- Molyneaux, P. L.
- O'Brien, A.
- O'Reilly, K.
- Packham, A.
- Parfrey, H.
- Poletti, V.
- Porter, J. C.
- Renzoni, E.
- Rivera-Ortega, P.
- Russell, A. M.
- Saini, G.
- Spencer, L. G.
- Stella, G. M.
- Stone, H.
- Sturney, S.
- Thickett, D.
- Thillai, M.
- Wallis, T.
- Ward, K.
- Wells, A. U.
- West, A.
- Wickremasinghe, M.
- Woodhead, F.
- Hearson, G.
- Howard, L.
- Baillie, J. K.
- Openshaw, P. J. M.
- Semple, M. G.
- Stewart, I.
- Jenkins, R. G.
Keywords
- COVID-19, IPF, ILD, Obesity, Lung Function, hospitalisation